- Filed
- Dec 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Dec 3, 2025 | 27.96M sh |
| Shares Diluted | Q3 2026 · Nov 1, 2025 | 27.94M sh |
| Shares Diluted | Q3 2026 · Nov 1, 2025 | 27.98M sh |
| Shares Diluted | Q3 2026 · Nov 2, 2024 | 28.07M sh |
| Shares Diluted | Q3 2026 · Nov 2, 2024 | 29.34M sh |
| Stock Repurchased | Q3 2026 · Nov 1, 2025 | $0 |
| Stock Repurchased | Q3 2026 · Nov 2, 2024 | $21.18M |
| Capex | Q3 2026 · Nov 1, 2025 | $3.07M |
| Capex | Q3 2026 · Nov 2, 2024 | $6.05M |
| Operating Cash Flow | Q3 2026 · Nov 1, 2025 | −$27.3M |
| Operating Cash Flow | Q3 2026 · Nov 2, 2024 | −$35.76M |
| Cash And Equivalents | Q3 2026 · Nov 1, 2025 | $10.73M |
| Cash And Equivalents | Q3 2026 · Feb 1, 2025 | $28.63M |
| Stockholders Equity | Q3 2026 · Nov 1, 2025 | $128.06M |
| Stockholders Equity | Q3 2026 · Feb 1, 2025 | $178.96M |
| Current Liabilities | Q3 2026 · Nov 1, 2025 | $48.62M |
| Current Liabilities | Q3 2026 · Feb 1, 2025 | $57.99M |
| Total Liabilities | Q3 2026 · Nov 1, 2025 | $115.62M |
| Total Liabilities | Q3 2026 · Feb 1, 2025 | $127.74M |
| Current Assets | Q3 2026 · Nov 1, 2025 | $122.34M |
| Current Assets | Q3 2026 · Feb 1, 2025 | $164.87M |
| Total Assets | Q3 2026 · Nov 1, 2025 | $243.68M |
| Total Assets | Q3 2026 · Feb 1, 2025 | $306.69M |
| Eps Diluted | Q3 2026 · Nov 1, 2025 | −$0.44 |
| Eps Diluted | Q3 2026 · Nov 1, 2025 | −$1.80 |
| Eps Diluted | Q3 2026 · Nov 2, 2024 | −$0.46 |
| Eps Diluted | Q3 2026 · Nov 2, 2024 | −$0.52 |
| Eps Basic | Q3 2026 · Nov 1, 2025 | −$0.44 |
| Eps Basic | Q3 2026 · Nov 1, 2025 | −$1.80 |
| Eps Basic | Q3 2026 · Nov 2, 2024 | −$0.46 |
| Eps Basic | Q3 2026 · Nov 2, 2024 | −$0.52 |
| Sga Expense | Q3 2026 · Nov 1, 2025 | $38.67M |
| Sga Expense | Q3 2026 · Nov 1, 2025 | $119.92M |
| Sga Expense restated | Q3 2026 · Nov 2, 2024 | $46.7M |
| Sga Expense restated | Q3 2026 · Nov 2, 2024 | $136.25M |
| Net Income | Q3 2026 · Nov 1, 2025 | −$12.37M |
| Net Income | Q3 2026 · Nov 1, 2025 | −$50.5M |
| Net Income | Q3 2026 · Aug 2, 2025 | −$4.67M |
| Net Income | Q3 2026 · May 3, 2025 | −$33.46M |
| Net Income | Q3 2026 · Nov 2, 2024 | −$12.8M |
| Net Income | Q3 2026 · Nov 2, 2024 | −$15.22M |
| Net Income | Q3 2026 · Aug 3, 2024 | $5.71M |
| Net Income | Q3 2026 · May 4, 2024 | −$8.12M |
| Operating Income | Q3 2026 · Nov 1, 2025 | −$12.17M |
| Operating Income | Q3 2026 · Nov 1, 2025 | −$34.62M |
| Operating Income restated | Q3 2026 · Nov 2, 2024 | −$8.15M |
| Operating Income restated | Q3 2026 · Nov 2, 2024 | −$16.38M |
| Gross Profit | Q3 2026 · Nov 1, 2025 | $26.19M |
| Gross Profit | Q3 2026 · Nov 1, 2025 | $84.45M |
| Gross Profit restated | Q3 2026 · Nov 2, 2024 | $38.42M |
| Gross Profit restated | Q3 2026 · Nov 2, 2024 | $119.17M |
| Cost Of Revenue | Q3 2026 · Nov 1, 2025 | $36.07M |
| Cost Of Revenue | Q3 2026 · Nov 1, 2025 | $100.31M |
| Cost Of Revenue restated | Q3 2026 · Nov 2, 2024 | $32.07M |
| Cost Of Revenue restated | Q3 2026 · Nov 2, 2024 | $113.27M |
| Revenue | Q3 2026 · Nov 1, 2025 | $62.25M |
| Revenue | Q3 2026 · Nov 1, 2025 | $184.76M |
| Revenue restated | Q3 2026 · Nov 2, 2024 | $70.48M |
| Revenue restated | Q3 2026 · Nov 2, 2024 | $232.43M |